Medable’s Decentralized Clinical Trial platform is the industry’s first digital clinical trial platform that improves research by enabling every biology to easily participate in trials anywhere in the world while driving precise outcomes and scaling to fit the needs of any protocol.

Built by a combination of clinicians, patient advocates, and technology experts, the Medable platform eases the trial experience for all using an intuitive design experience that’s proven to increase efficiencies, streamline workflows, and keep users engaged.

This approach has garnered Medable great success, including the first-ever treatment approved by the FDA using a DCT approach in which a dermatology treatment gained approval with no FDA findings.